EvolveImmune Therapeutics

EvolveImmune Therapeutics is a private biotechnology company developing first-in-category, multifunctional immunotherapies for cancer and autoimmune diseases. Leveraging its proprietary EVOLVE platform, the company is advancing a pipeline of trispecific T cell engagers with integrated CD2 costimulation to address unmet needs in oncology and immunology. EvolveImmune is recognized for its innovative approach to overcoming cancer-driven immunodeficiency and resistance to current immune therapies.

Company Facts

• Headquarters: Branford, United States
• Founded: 2019
• Employees: 50
• Type: Private Company
• Website: https://evolveimmune.com
• Industries: Biotechnology, Pharmaceuticals, Immunotherapy, Oncology, Healthcare